Kovitz Investment Group Partners
PROF

Kovitz Investment Group Partners’s Profound Medical PROF Stock Holding History

Kovitz Investment Group Partners’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,722
Closed -$81.7K – 1104
2025
Q3 		$81.7K Hold
16,722
– – ﹤0.01% 1377
2025
Q2 		$98.7K Buy
+16,722
New +$88.4K ﹤0.01% 1326

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Kovitz Investment Group Partners's PROF Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 16,722 shares — an estimated $81.7K sold.

Kovitz Investment Group Partners first reported a position in PROF in Q2 2025 and held it in 2 quarters. The position peaked at $98.7K in Q2 2025. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 16,722 Profound Medical shares in Q4 2025, an estimated $81.7K.
  • Kovitz Investment Group Partners first reported a position in Profound Medical in Q2 2025 and held it in 2 quarters.
  • Kovitz Investment Group Partners's Profound Medical position peaked at $98.7K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.